×
For best experience we recommend to activate Javascript in your browser.
LY75/DEC-205 antibody (AA 216-501)
The Mouse Monoclonal anti-LY75/DEC-205 antibody has been validated for WB, IHC, IP and ICC. It is suitable to detect LY75/DEC-205 in samples from Human.
Quick Overview for LY75/DEC-205 antibody (AA 216-501) (ABIN7621859)
Target
See all LY75/DEC-205 (LY75) Antibodies
LY75/DEC-205 (LY75)
(Lymphocyte Antigen 75 (LY75))
Reactivity
All reactivities for LY75/DEC-205 antibodies
Human
Host
All hosts for LY75/DEC-205 antibodies
Mouse
Clonality
All clonalities for LY75/DEC-205 antibodies
Monoclonal
Conjugate
All conjugates for LY75/DEC-205 antibodies
This LY75/DEC-205 antibody is un-conjugated
Application
All applications for LY75/DEC-205 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Clone
C21
Product Details anti-LY75/DEC-205 Antibody
(hide)
Binding Specificity
All epitopes for LY75/DEC-205 antibodies
AA 216-501
Purpose
Lymphocyte Antigen 75 (LY75) Monoclonal Antibody
Sequence
Cys216~Cys501
Characteristics
The Lymphocyte Antigen 75 (LY75) Monoclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Protein A + Protein G affinity chromatography
Isotype
IgG1 kappa
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
1 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for LY75/DEC-205
(hide)
Target
LY75/DEC-205 (LY75)
(Lymphocyte Antigen 75 (LY75))
Alternative Name
LY75
Gene ID
100526664
UniProt
O60449
Recently viewed
(hide)
Chat with us , powered by LiveChat